| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871761 | The Annals of Thoracic Surgery | 2019 | 6 Pages |
Abstract
Our experience indicates that SRS is safe, and offers an alternative modality for selected patients with recurrent oligometastatic or persistent lung cancer. Thoracic surgeons should actively participate in SRS and continue to evaluate the efficacy of this treatment strategy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Arjun MD, James D. MD, Dwight E. MD, Matthew J. MD, Valentino DO, MPH, David MD, Steven MD, Ghulam MD, William E. MS, Cihat PhD, Rodney J. MD, Neil A. MD,